March 27, 2012

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the "GE Healthymagination Cancer Challenge." Read more...

Vanderbilt Heart uses first FDA-approved treatment for heart disease patients who also have diabetes


Vanderbilt Heart recently used a newly approved medical device to open narrowed coronary arteries, even in heart disease patients who also have diabetes. The U.S. Food and Drug Administration (FDA) recently approved this new device - the Resolute Integrity Drug-Eluting Stent (DES) from Medtronic - and Vanderbilt took part in a clinical study that supported its approval. Read more...

From Momentum magazine: Tipping the scales toward cancer?


Timothy Zeien had quite a list of concerns surrounding his weight - but cancer was not among them. At 230 pounds, the 64-year-old had type 2 diabetes and was taking cholesterol- and blood pressure-lowering medications. In February 2011, Zeien made a major decision: to undergo a bariatric procedure called gastric sleeving. He says doctors had been encouraging him to do something for a long time, but he became serious about it when he and his wife moved to Tennessee to help their daughter, a pediatric emergency physician at Vanderbilt, with her children. Read more...

This Week on VUCast, Vanderbilt's weekly newscast highlighting research, experts, students, sports and everything Vanderbilt


This week's VUCast : How teachers on the front lines of urban schools can get a free master's degree. Plus, Vandy's ties to a big movie and sex for life! Read more...